In a study presented at the ECNP Congress in Milan, a comparison was made between psilocybin and escitalopram, a common SSRI antidepressant. The study found that over a 6-month period, both treatments showed similar improvements in depressive symptoms. However, patients taking psilocybin reported better psychological well-being, social functioning, and a greater sense of meaning in life. Psilocybin also showed additional benefits like improved sexual drive compared to SSRIs. The researchers suggested that psilocybin therapy could offer a more holistic treatment option for depression. The study involved 59 patients with moderate to severe depression and highlighted the potential positive mental health benefits of psilocybin.
Source link
Study shows psilocybin gives comparable long-term antidepressant effects to standard antidepressants
